BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18482577)

  • 21. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.
    Cifuentes G; Espejo F; Vargas LE; Parra C; Vanegas M; Patarroyo ME
    Biochemistry; 2004 Jun; 43(21):6545-53. PubMed ID: 15157087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.
    Patarroyo ME; Cifuentes G; Piraján C; Moreno-Vranich A; Vanegas M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):529-35. PubMed ID: 20206601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phi (Φ) and psi (Ψ) angles involved in malarial peptide bonds determine sterile protective immunity.
    Patarroyo ME; Moreno-Vranich A; Bermúdez A
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):75-80. PubMed ID: 23142598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.
    Cifuentes G; Patarroyo ME; Reyes C; Córtes J; Patarroyo MA
    Biochem Biophys Res Commun; 2007 Aug; 360(1):149-55. PubMed ID: 17588541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective.
    Cifuentes G; Patarroyo ME; Urquiza M; Ramirez LE; Reyes C; Rodriguez R
    J Med Chem; 2003 May; 46(11):2250-3. PubMed ID: 12747797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high immunogenicity induced by modified sporozoites' malarial peptides depends on their phi (ϕ) and psi (ψ) angles.
    Patarroyo ME; Bermudez A; Alba MP
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):81-6. PubMed ID: 23142229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides.
    Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A
    Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of amino acid electron-donor/acceptor atoms in host-cell binding peptides is associated with their 3D structure and HLA-binding capacity in sterile malarial immunity induction.
    Patarroyo ME; Almonacid H; Moreno-Vranich A
    Biochem Biophys Res Commun; 2012 Jan; 417(3):938-44. PubMed ID: 22197813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein.
    Saravia C; Martinez P; Granados DS; Lopez C; Reyes C; Patarroyo MA
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1279-83. PubMed ID: 19000655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6746 SERA peptide analogues immunogenicity and protective efficacy against malaria is associated with short alpha helix formation: malaria protection associated with peptides alpha helix shortening.
    Alba MP; Salazar LM; Puentes A; Pinto M; Torres E; Patarroyo ME
    Peptides; 2003 Jul; 24(7):999-1006. PubMed ID: 14499278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
    Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D structure and immunogenicity of Plasmodium falciparum sporozoite induced associated protein peptides as components of fully-protective anti-malarial vaccine.
    Alba MP; Almonacid H; Calderón D; Chacón EA; Poloche LA; Patarroyo MA; Patarroyo ME
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):349-55. PubMed ID: 22115782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against experimental P falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures.
    Cubillos M; Salazar LM; Torres L; Patarroyo ME
    Biochimie; 2002 Dec; 84(12):1181-8. PubMed ID: 12628294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure.
    Lozano JM; Alba MP; Vanegas M; Silva Y; Torres-Castellanos JL; Patarroyo ME
    Biol Chem; 2003 Jan; 384(1):71-82. PubMed ID: 12674501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis for peptide-based antimalarial vaccine development targeting erythrocyte invasion by P. falciparum.
    Aza-Conde J; Reyes C; Suárez CF; Patarroyo MA; Patarroyo ME
    Biochem Biophys Res Commun; 2021 Jan; 534():86-93. PubMed ID: 33316544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against experimental malaria associated with AMA-1 peptide analogue structures.
    Salazar LM; Alba MP; Torres MH; Pinto M; Cortes X; Torres L; Patarroyo ME
    FEBS Lett; 2002 Sep; 527(1-3):95-100. PubMed ID: 12220641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
    Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
    Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.
    Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G
    Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.